federal_register: 2017-05247
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-05247 | Public Meeting on Patient-Focused Drug Development for Sarcopenia; Request for Comments; Correction | Notice | The Food and Drug Administration is correcting a notice entitled "Public Meeting on Patient-Focused Drug Development for Sarcopenia" that appeared in the Federal Register of December 14, 2016 (81 FR 90361). The document announced a public meeting and an opportunity for public comment on Patient-Focused Drug Development for Sarcopenia. The location of the meeting has changed and this document provides the updated meeting location. | 2017-03-16 | 2017 | 3 | https://www.federalregister.gov/documents/2017/03/16/2017-05247/public-meeting-on-patient-focused-drug-development-for-sarcopenia-request-for-comments-correction | https://www.govinfo.gov/content/pkg/FR-2017-03-16/pdf/2017-05247.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration is correcting a notice entitled "Public Meeting on Patient-Focused Drug Development for Sarcopenia" that appeared in the Federal Register of December 14, 2016 (81 FR 90361). The document announced a public meeting and... |